CD34 and acute myeloid leukemia: To assess changes in phenotypes, we analyzed the cell surface markers of leukemic stem/progenitor cells using a flow cytometric analysis of CD34- and CD38- expression in 29 paired bulk primary AML cells and the human CD45+ fraction of their engrafted AML-PDX BM cells (Supplementary Table 2).